https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition-3 Biotech Morning en 2026-08-13T14:20:07.880Z Vertex Just Dropped $10 Billion on a Company You've Probably Never Heard Of https://biotechmorning.com/news/gilead-ouro-medicines-acquisition Biotech Morning en 2026-08-13T14:19:23.428Z Gilead Just Dropped $2.175 Billion on a Company You've Never Heard Of https://biotechmorning.com/news/zipalertinib-rezilient3-egfr-exon20-lung-cancer Biotech Morning en 2026-08-13T14:18:37.773Z The Lung Cancer Mutation That Stumped Every Drug Might Finally Have a Match https://biotechmorning.com/news/crispr-problem-cells-not-scissors Biotech Morning en 2026-08-13T14:17:50.432Z CRISPR's Biggest Problem Isn't the Scissors. It's the Cells. https://biotechmorning.com/news/biotech-1-2-billion-ipo-day-braveheart-kardigan-eikon Biotech Morning en 2026-08-13T14:17:04.898Z Biotech's Big IPO Stretch That Nobody Saw Coming https://biotechmorning.com/news/china-us-clinical-trial-regulatory-divergence Biotech Morning en 2026-08-13T14:16:14.398Z The Two Biggest Drug Markets Are Heading in Opposite Directions https://biotechmorning.com/news/novo-nordisk-amazon-drug-discovery-hub Biotech Morning en 2026-08-13T14:15:35.192Z Novo Nordisk Just Handed Amazon the Keys to Its Drug Lab https://biotechmorning.com/news/lilly-retatrutide-black-market-lawsuits Biotech Morning en 2026-08-13T14:14:49.358Z Lilly's Next Blockbuster Isn't Even Approved Yet. The Black Market Didn't Wait. https://biotechmorning.com/news/vykat-prader-willi-safety-concerns Biotech Morning en 2026-08-13T14:14:06.683Z The First Drug for an 'Always Hungry' Disease Just Hit a Wall https://biotechmorning.com/news/novartis-myricx-bio-adc-acquisition-3 Biotech Morning en 2026-08-13T14:13:24.623Z Novartis Just Paid $1.1 Billion for a Drug That Hasn't Touched a Human https://biotechmorning.com/news/jj-sail-biomedicines-acquisition-option-immunology Biotech Morning en 2026-08-13T14:12:39.044Z J&J Just Put a $2.58 Billion Price Tag on a Company Most People Haven't Heard Of https://biotechmorning.com/news/moonlake-immunotherapeutics-data-transparency-concerns Biotech Morning en 2026-08-12T14:20:33.438Z What Is MoonLake Immunotherapeutics Afraid Of? https://biotechmorning.com/news/ivonescimab-china-squamous-nsclc-approval Biotech Morning en 2026-08-12T14:19:52.392Z The Two-in-One Cancer Drug China Can't Stop Approving https://biotechmorning.com/news/zydus-sentynl-mereo-alvelestat-rare-lung-disease-deal Biotech Morning en 2026-08-12T14:19:04.726Z Zydus Just Bet Big on a Lung Disease Most People Haven't Heard Of https://biotechmorning.com/news/pharma-us-manufacturing-tariff-wave Biotech Morning en 2026-08-12T14:18:19.558Z Half a Trillion Reasons Big Pharma Is Building Factories in America https://biotechmorning.com/news/definium-lsd-anxiety-second-phase-3-win Biotech Morning en 2026-08-12T14:17:37.174Z An LSD Pill Just Aced Its Second Anxiety Trial. Yes, Really. https://biotechmorning.com/news/itm-11-fda-rejection-manufacturing Biotech Morning en 2026-08-12T14:16:51.253Z The Drug That Worked Perfectly But Still Can't Reach Patients https://biotechmorning.com/news/vertex-cf-fortress-sionna-trial-failure Biotech Morning en 2026-08-12T14:16:08.443Z Vertex's $10 Billion CF Fortress Just Lost Its Last Serious Challenger https://biotechmorning.com/news/curium-lantheus-8-billion-radiopharmaceutical-deal Biotech Morning en 2026-08-12T14:15:42.091Z Radioactive Real Estate Just Got Its Biggest Buyer Ever https://biotechmorning.com/news/trump-executive-order-childhood-vaccine-schedule-cut Biotech Morning en 2026-08-12T14:14:53.524Z The White House Just Rewrote Your Kid's Shot Card https://biotechmorning.com/news/jazz-actio-biosciences-kcnt1-epilepsy-deal Biotech Morning en 2026-08-12T14:14:09.900Z Jazz Just Bet $1.3 Billion on a Disease Most Doctors Have Never Heard Of https://biotechmorning.com/news/fda-bespoke-gene-therapy-framework-3 Biotech Morning en 2026-08-12T14:13:21.877Z The FDA Just Made It Possible to Build a Drug for One Person